Kentucky 2022 Regular Session

Kentucky House Bill HB529

Introduced
2/17/22  
Refer
2/17/22  
Refer
3/2/22  
Report Pass
3/3/22  
Engrossed
3/10/22  
Refer
3/10/22  
Refer
3/16/22  
Report Pass
3/23/22  
Refer
3/29/22  
Enrolled
3/30/22  
Enrolled
3/30/22  
Chaptered
4/8/22  

Caption

AN ACT relating to the disclosure of laboratory test results and declaring an emergency.

Impact

By amending KRS Chapter 333, HB 529 directly impacts the responsibilities of medical laboratories and health care providers in Kentucky. It mandates that results from certain sensitive tests are withheld for a short period to ensure that physicians have adequate time to interpret the results before discussing them with patients. This is intended to enhance patient safety and care quality by allowing healthcare providers to offer specific advice and emotional support in potentially distressing situations.

Summary

House Bill 529 focuses on the disclosure of laboratory test results within Kentucky's healthcare system. The bill establishes regulations that health care providers must follow regarding the immediate electronic release of test results to patients. This legislation is in response to both federal requirements outlined in the 21st Century Cures Act and concerns about the implications of immediate test result access for patients. Notably, the bill specifies exceptions where certain results, such as those indicating potential malignancies or genetic markers, should not be disclosed until 72 hours after finalization, providing healthcare providers additional time to prepare appropriate guidance for the patient.

Sentiment

The general sentiment around HB 529 is mixed, reflecting a balance between patient autonomy and necessary medical oversight. Supporters of the bill argue it enhances patient care by preventing the premature release of unsettling test results. Conversely, critics express concerns about patients’ right to immediate access to their health information, highlighting the need for transparency in healthcare. The debate centers around the ethical considerations of patient information access and provider responsibilities.

Contention

Key points of contention include the debate over how much control patients should have over their health information versus the need for protective measures that allow providers to manage the release of sensitive data. The provisions in HB 529 that delay the release of specific test results have raised questions about informed consent and the extent to which patients should be shielded from distressing news until qualified healthcare providers have delivered it. This tension touches upon broader issues of trust and communication within the patient-provider dynamic.

Companion Bills

No companion bills found.

Previously Filed As

KY HB1732

Health records; disclosure of laboratory test results.

KY HB973

Health records; disclosure of laboratory test results, waiting period.

KY HB973

An Act to amend and reenact § 32.1-127.1:03 of the Code of Virginia and to amend the Code of Virginia by adding a section numbered 32.1-127.1:06, relating to health records; disclosure of laboratory test results; waiting period.

KY HB822

AN ACT relating to coverage for colorectal cancer examinations and laboratory tests and declaring an emergency.

KY S2475

Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.

KY S4263

Establishes "Sensitive Life-Changing Test Results Protection Act."

KY SB2761

RESULTS Act Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025

KY HB5269

RESULTS Act Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025

KY SB2402

Approved laboratory tests; and to provide an effective date.

KY H2395

Relative to clinical laboratories

Similar Bills

CA AB304

Training programs: clinical laboratories and personnel: grants.

CA SB339

Medi-Cal: laboratory rates.

NJ A4877

Requires health insurance and Medicaid reimbursement of clinical laboratories regardless of managed care plan participation.

CA AB481

An act to amend Section 1269 of, and to add Section 1206.

LA HB1216

Provides relative to the guidelines for clinical laboratory personnel

FL H0115

Clinical Laboratory Personnel

HI SB1154

Relating To Health.

HI SB1154

Relating To Health.